Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Research team develops actionable tool to assess risk for premature births

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

AHA: Study examines impact of adequate prenatal care for congenital heart disease

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

Severe nausea during pregnancy and depression: Study reveals bidirectional association

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Todays Updates

NeurologyLive® Year in Review 2025: Notable Trials Beginning This Year NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review 2025, we've compiled some notable trials that began in 2025.

NeuroVoices: Joseph Sullivan, MD, on ETX101 Gene Regulation Therapy and Early POLARIS Findings in Dravet Syndrome Marco Meglio

The director of the Pediatric Epilepsy Center at UCSF reviewed recently presented interim phase 1/2 data for ETX101, a one-time AAV9 gene regulation therapy aiming to increase SCN1A expression in inhibitory interneurons in Dravet syndrome.

NeurologyLive® Year in Review 2025: Top Interviews in Multiple Sclerosis Care NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews regarding multiple sclerosis in 2025.

Hidradenitis Suppurativa in 2025: Year in Review

Hidradenitis Suppurativa in 2025: Year in Review

Todays Updates

NeurologyLive® Year in Review 2025: Notable Trials Beginning This Year NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review 2025, we've compiled some notable trials that began in 2025.

NeuroVoices: Joseph Sullivan, MD, on ETX101 Gene Regulation Therapy and Early POLARIS Findings in Dravet Syndrome Marco Meglio

The director of the Pediatric Epilepsy Center at UCSF reviewed recently presented interim phase 1/2 data for ETX101, a one-time AAV9 gene regulation therapy aiming to increase SCN1A expression in inhibitory interneurons in Dravet syndrome.

NeurologyLive® Year in Review 2025: Top Interviews in Multiple Sclerosis Care NeurologyLive® Staff

As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews regarding multiple sclerosis in 2025.

Hidradenitis Suppurativa in 2025: Year in Review

Hidradenitis Suppurativa in 2025: Year in Review

Latest News

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

News All Time

New study shows long-term effectiveness of HPV vaccine

A new study has confirmed that the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.

Exercise reduces risk of common postpartum pelvic floor problems

Targeted pelvic floor muscle training in the first year postpartum significantly reduces the risk of two common pelvic floor disorders, according to a study that rewrites the longstanding narrative that these disorders are ...

Problems with regulating emotions during pregnancy may help predict perinatal depression

Around 1 in 5 mothers experience perinatal depression. This condition involves depressive episodes during pregnancy or just after birth—often with lasting effects on both mother and child.

Sugar–protein interactions, critical for placenta during early pregnancy, shed light on common complications

During the first weeks of pregnancy, the developing placenta in a mother's womb undergoes a dramatic change. Individual cells merge, forming a continuous barrier that will spend the next nine months ferrying oxygen and nutrients ...

The quiet collapse of America's reproductive health safety net

In late October, Maine Family Planning announced three rural clinics in northern Maine would close by month's end. These primary care and reproductive health clinics served about 800 patients, many uninsured or on Medicaid.

Meta-analysis evaluates effectiveness of various psychological therapies for perinatal depression

A systematic review and meta-analysis evaluated the effectiveness of psychological therapies for perinatal depression, the most prevalent maternal mental health disorder. The review, published in the Annals of Internal Medicine, ...

Wildfire smoke exposure during pregnancy linked to higher risk of preterm birth

About 10% of American babies are born prematurely. Birth before 37 weeks can lead to a cascade of health risks, both immediate and long-term, making prevention a vital tool for improving public health over generations.

Back pain during pregnancy is often dismissed as a passing discomfort—a nurse explains why it should be taken seriously

About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to preventable suffering and harm. Many mothers avoid medications and treatments during pregnancy ...

Researchers discuss gaps, obstacles and solutions for contraception

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in modern contraception over the past 60 years, many gaps remain and the rate of unplanned pregnancies ...

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including speech delays, autism, motor disorders, and other developmental delays, ...

Safeguarding fertility: Study investigates key hormone for women with cancer choosing fertility preservation

Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects ...

Breast cancer risk varies between different hormonal contraceptives, research reveals

Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and ...

Punitive drug laws may deter prenatal care and hospital-based delivery

States that explicitly criminalize prenatal drug use may unintentionally discourage pregnant people from seeking essential medical care, according to new research from Columbia University Mailman School of Public Health. ...

Highlighting key therapies that support women through high-risk pregnancies 

Joint research from Edith Cowan University (ECU) and the University of St. Augustine for Health Sciences, in the US, is shedding new light on the broader potential of psychosocial occupational therapy, revealing it can play ...

Study shows Australian preterm birth prevention program is working

New data has shown that an initiative to reduce preterm births in Australia has led to a significant decrease in rates of potentially harmful early birth and improved pregnancy outcomes for women across the country.

Vitamin D deficiency increases risk of complicated deliveries, finds study

A research team at Uppsala University has identified a clear link between osteomalacia—a form of bone softening commonly caused by vitamin D deficiency—and a fivefold increased risk of emergency cesarean sections or the ...

Recommended News For You

High weight and obesity are associated with poor outcomes in leukemia treatment.

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

Scientists pioneer noninvasive 3D imaging to enhance skin cancer management

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

When it comes to obesity-related cancers, where you shop for food matters

Recommended Articles For You

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement? 

Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology 

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

2.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

3.

Chemo causes lasting physical decline in breast cancer survivors

4.

Some triple negative breast cancers might be avoided by longer breastfeeding

5.

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

1.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

2.

AI in Cancer Diagnostics and Imaging Interpretation

3.

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology

4.

Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer

5.

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

3.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot